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Abstract
Background: Chewing ability is often compromised in patients with oral cancer.
The aim of this study was to identify which factors affect masticatory performance
in these patients.
Methods: Patients with primary oral cancer were assessed for up to 5 years after
primary treatment. Healthy controls were assessed once. A mixed-model analysis
was performed, with masticatory performance as outcome measure.
Results: A total of 123 patients were included in the study. Factors positively asso-
ciated with masticatory performance were number of occlusal units (OU), having
functional dentures, and maximum mouth opening (MMO). The impact of tumor
location and maximum bite force (MBF) differed per assessment moment. Mastica-
tory performance declined for up to 1 year but recovered at 5 years after treatment.
Conclusion: Masticatory performance in patients treated for oral cancer is affected
by MBF, MMO, number of OU, and dental status. These should be the focus of
posttreatment therapy.
KEYWORDS
bite force, head and neck neoplasms, mastication, mixed model analysis,
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1 | INTRODUCTION
The aim of curative treatment for oral malignancies is dis-
ease remission achieved by radical resection and, on indica-
tion, postoperative irradiation. A great challenge for this
curative treatment is trying to maintain or restore acceptable
functional and esthetical outcomes after treatment. Oral
function (eating, speaking, drinking, and swallowing) is
known to be lower in patients who have had tumor surgery
in the oral cavity than in healthy subjects.1–3 Masticatory
performance is an important aspect of posttreatment quality
of life in patients treated for head and neck cancer.4–6
Oncological surgery removes malignancies at the cost of
functional anatomy.7 After ablation of the tumor, where pri-
mary closure is impossible, reconstruction is necessary either
immediately after the ablation of the tumor or in a secondary
stage and is achieved using a local flap, bone grafts, microvas-
cular free-tissue transfer, and/or implant surgery. Often, dental
rehabilitation with a prosthesis is used to restore oral function
and esthetics8; however, different phases of mastication may
still be affected, such as the transportation, trituration, and
consolidation of the food bolus.9,10 Patients who undergo a
glossectomy may, for example, have difficulty with the trans-
portation of food, whereas patients who have had a
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mandibulectomy can experience difficulty in trituration and
vertical mobility during mastication.11 Radiotherapy can
cause masticatory impairment due to tooth loss, mucositis,
fibrosis, trismus, or xerostomia. Additionally, a lack of saliva
can make patients unable to tolerate dentures.3,12,13
Oral rehabilitation can improve masticatory performance.
To achieve optimal oral rehabilitation, it is important to iden-
tify factors that affect masticatory performance in patients
treated for oral cancer. Previous studies on this patient group
focused mainly on the subjective appraisal of chewing ability
using questionnaires; very few studies have assessed masti-
catory performance with an objective method.14–16
The primary aim of this study was to identify and quan-
tify factors involved in objective masticatory performance
for patients who have been treated for oral cavity malignan-
cies, with a follow-up of 5 years after treatment. We also
compared these results to healthy controls.
2 | SUBJECTS AND METHODS
2.1 | Patients
In this multicenter prospective cohort research, the study
population consisted of patients with a primary malignant
tumor involving the oral cavity who were referred to Univer-
sity Medical Center Utrecht (UMCU) or Radboud University
Medical Center (Radboudumc) between January 2007 and
August 2009. Patients were included if they were being trea-
ted with a curative intent, using surgery or surgery followed
by radiotherapy. Exclusion criteria included inoperability, a
previous and/or current second primary malignancy, cogni-
tive impairment, or the inability to understand Dutch. Sixty
age-matched controls were also recruited, whose details
were published previously.17 The experimental protocol was
approved by the Ethics Committees of the UMCU and
Radboudumc. All patients received written information and
provided their signed informed consent.
Pretreatment oral screening and dental management were
performed for all patients. Adjuvant radiotherapy, when
given, started within 4-6 weeks after surgery, in accordance
with the Dutch Head and Neck Society treatment guidelines,
with a total radiation dosage of 64-70 Gy.
Tumor locations included in this study were included
codes C00, C02-C06, and C31, defined by the WHO Inter-
national Classification of Diseases Oncology, third edition.18
Maxillary tumors included the upper alveolar process, tuber
maxillae, palate, and maxillary sinus (C03.0, C05, C31.0).
Mandibular tumors included the lower alveolar process, the
retromolar trigonum, the buccal mucosa, and the lower lip
(C00.4, C03.1, C06.0, C06.1, C06.2). Tongue and/or floor
of the mouth (TFM) tumors included the tongue and the
anterior floor of the mouth (C02, C04).
Patient information, including sex, tumor location and
size (pT of TNM-classification19), resection site, and details
of reconstruction, was extracted from medical records. Age,
smoking habit, and alcohol consumption were charted at the
pretreatment session. Smoking habit was scored as “No” for
nonfrequent or infrequent smokers and “Yes” for daily
smokers. Alcohol consumption scored “Yes” if it exceeded
1 unit per day on average.
2.2 | Assessments
Patients were assessed no more than 4 weeks before primary
treatment (baseline, t0), then at 4-6 weeks after surgery (t1a)
and/or 4-6 weeks after radiotherapy (t1b), 6 months (t2),
1 year (t3), and 5 years (t5) after their primary treatment. At
every assessment, masticatory performance, maximum bite
force (MBF), and maximum mouth opening (MMO) was
evaluated, as well as dental status and the presence of an
obturator prosthesis. Healthy controls were assessed once.
2.3 | Masticatory performance
The mixing ability test (MAT) measures how well a subject
mixes a 2-colored wax tablet by chewing on it.17,20 The wax
is a soft material (Plasticine modeling wax, non-toxic DIN
EN-71) that forms a compact bolus during chewing. The tab-
let was offered to patients at room temperature (20C). The
tablet had a diameter of 20 mm and consisted of two 3-mm
layers of bright red and blue wax. Chewing mixes the colors
to yield intermediate shades of red and blue. After being
chewed, the wax was flattened to a thickness of 2.0 mm and
photographed on both sides using a high-quality scanner
(Epson V750; Long Beach, California). The wax images
were analyzed using Adobe Photoshop CS3 (San Jose, Cali-
fornia) to generate a measure for the spread of red and blue
intensities: the Mixing Ability Index (MAI). A lower index
implies a better mixed tablet, hence better masticatory per-
formance. The MAI ranges from 0 to 30.
2.4 | Maximum bite force measurement
MBF was measured using a bite force transducer.21 The
device consists of a unilateral strain gauge with a surface
area of 100 mm2 and a vertical height of 2.8 mm. It was cov-
ered with a hard putty for dental protection and mounted on
a mouthpiece. The strain gauge element was placed between
the first molars to measure the occlusal forces when subjects
clenched their jaws together as hard as possible. Two mea-
surements each were taken from the left and right sides. The
mean of the highest measurements on the left and right sides
is presented as the MBF.
2.5 | Maximum mouth opening measurement
MMO was measured extraorally using a previously published
protocol.22 Briefly, the distance between applied markings on
the inferior border of the chin and the tip of the nose was mea-
sured in patients in a resting position, as well as when opening
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the mouth as far as possible. Both positions were measured
twice at every assessment. The difference between the average
of the 2 resting positions and the highest value of the 2 maxi-
mum opening positions was defined as the MMO.
2.6 | Dental status
Dental status was assessed and stratified into the following
groups: edentulous (ED), full denture in upper and lower
jaw (FD), full denture in upper or lower jaw combined with
implant retention in upper or lower jaw (FD&FDI), full den-
ture in upper or lower jaw and dentate in the other jaw
(FD&D), full denture with implant retention in upper and
lower jaw (FDI&FDI), full denture with implant retention in
upper or lower jaw and dentate in the other jaw (FDI&D), or
dentate upper and lower jaw (D&D). Partially dentate jaws
were classified as dentate. Additionally, pairs of natural
occluding premolars and molars were counted and scored,
respectively, as 1 and 2 occlusal units (OU).23
2.7 | Obturator prosthesis
When maxillary defects could not be closed primarily, a
temporary obturator was fabricated based on preoperative
assessments and dental casts. After approximately 1 year,
the patient was provided with the definite obturator, made of
acrylic resin, based on Beumer's method.24 The presence or
absence of an obturator prosthesis was scored as “Yes” or
“No,” respectively.
2.8 | Statistical analysis
Chi-square tests were used to analyze differences in patient
characteristics with respect to nominal and ordinal variables,
such as tumor location, whereas a one-way analysis of vari-
ance was used to examine the age differences among the
groups. Independent t tests were used to calculate the differ-
ences between mean values. The mean values of MAI,
MMO, MBF, OU (paired t test), and prosthetic status
(Wilcoxon signed rank test) did not differ between the t1a
and t1b time points, thus only the t1b values were presented
when the patient had undergone both these assessments (t1).
A linear mixed-effects model with the MAI as outcome
was constructed to assess both the changes over time and the
effect of patient characteristics and clinical parameters. To
account for within-patient correlations, a random patient factor
was added. Fixed-effect factors such as age, sex, tumor loca-
tion, alcohol consumption at baseline, tumor extent
(pT classification), treatment modality, surgical reconstruction,
assessment moment (t0-t5), smoking habit, dental status, num-
ber of OU, the presence of an obturator prosthesis, MMO, and
MBF during the follow up, as well as all 2-way interactions of
the factors during the assessment period, were assessed. The
factors that were not significant at a P < .05 level were
removed in a backward fashion, beginning with the interac-
tions, to build a parsimonious model with sufficient fit while
maintaining a hierarchical structure, meaning that if an interac-
tion was included in the model, the main effects were also
represented in the model. When an interaction with the assess-
ment moment was found for a specific variable, there was a
different coefficient for all levels of the variable at each assess-
ment moment. The coefficients of the significant covariates,
together with the value of the intercept of the mixed model
analysis, were combined into a formula for the estimated
MAI. The intercept is the value of the estimated MAI in the
event that all following coefficients remain zero. The addition
of coefficients of the significant covariates will, depending on
the coefficient being positive or negative, either increase or
decrease the estimated MAI. The formula was used to com-
pare the chewing performance of patients with tumors in the
3 location groups during the follow-up period. For each time
point, we filled the formula with the average variable values
for the significant coefficients in the 3 tumor location groups,
as calculated by a restricted maximum likelihood approach.
A P-value less than .05 was considered statistically sig-
nificant. The mixed-model analysis was performed using
SAS version 9.2 (SAS Institute, Cary, North Carolina). The
remaining tests were performed using SPSS 21 (IBM Corp.,
Armonk, New York).
3 | RESULTS
At t0, a total of 123 patients were enrolled in this study.
After 5 years, 69 patients were still in the study; 30 patients
died during the follow-up period and 24 patients chose to
stop participating for various reasons (Figure 1). Baseline
demographics and clinical characteristics categorized on pri-
mary tumor location are displayed in Table 1.
Thirty patients had maxillary tumors, 48 had maxillary
tumors, and 45 had TFM tumors. Of the 30 patients who
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FIGURE 1 Flowchart showing the number of subjects (n) at each
assessment stage and the average time since the primary oncological
treatment. TFM, Tongue/Floor of the Mouth
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underwent a maxillectomy, 20 received an obturator prosthe-
sis. In 11 of these 20 patients, the obturator was placed with-
out further surgical intervention covering the defect; in
1 patient, it was combined with a local flap; and in the other
9 patients, it was combined with a fasciocutaneous free flap.
Of the 48 patients with mandibular tumors, 18 had segmental
defects. Two patients with primary floor of the mouth tumors
had mandibular invasion to an extent that necessitated seg-
mental resection. Nine patients were reconstructed using a
reconstruction plate, of whom 3 combined with a
fasciocutaneous flap due to soft tissue deficiency. Seven
patients were reconstructed with a free vascularized bone flap
and 1 with a nonvascularized iliac crest graft. One patient's
segmental defect was not reconstructed due to comorbidity.
Sixty-four patients (52%) received postoperative radiotherapy
(Table 1).
At baseline, sex, smoking status, alcohol usage, and the
number of OU did not differ between patients with tumors in
different locations; however, significant differences were
observed between their MBF and masticatory performance,
TABLE 1 Baseline demographics, clinical characteristics, and assessments categorized by tumor location
Categorical variables, n (%)
Controls Maxilla Mandible TFM
(n = 60) (n = 30) (n = 48) (n = 45) P-valuea
Sex
Male 31 (51) 14 (47) 25 (52) 30 (67) .29
Female 29 (49) 16 (53) 23 (48) 15 (33)
Smoker
Yes 13 (22) 8 (27) 18 (38) 16 (36) .25
No 47 (78) 22 (73) 30 (62) 29 (64)
Alcohol use
Yes 30 (50) 8 (27) 15 (31) 19 (42) .09
No 30 (50) 22 (73) 33 (69) 26 (58)
pT-stage
T1 NA 5 (17) 14 (29) 23 (51) .000**
T2 NA 11 (37) 13 (27) 14 (31)
T3 NA 1 (3) 3 (6) 4 (9)
T4 NA 13 (43) 18 (38) 4 (9)
Dental status
ED 0 7 (23) 13 (27) 5 (11) .000**
FD 20 (33.3) 7 (23) 8 (17) 13 (29)
FD&FDI 20 (33.3) 0 (0) 2 (4) 4 (9)
FD&D 0 4 (14) 8 (17) 3 (7)
FDI&FDI 0 0 (0) 0 (0) 0 (0)
FDI&D 0 1 (3) 0 (0) 0 (0)
D 20 (33.3) 11 (37) 17 (35) 20 (44)
Treatment
Surgery NA 12 (40) 24 (50) 23 (51) .000**
Surgery and radiotherapy NA 18 (60) 24 (50) 22 (49)
Surgical reconstruction
No surgery 60 0 (0) 0 (0) 0 (0) .000**
Primary closure NA 17 (57) 16 (33) 23 (51)
Local flap NA 1 (3) 2 (4) 1 (2)
Fasciocutaneous free flap NA 12 (40) 12 (25) 19 (42)
Bone graft/flap NA 0 (0) 18 (38) 2 (4)
Categorical variables, n (%)
Controls Maxilla Mandible TFM
P-valueb(n = 60) (n = 30) (n = 48) (n = 45)
Age (y) 60.3 (7.2) 68.7 (12.3) 66.7 (12.7) 61.4 (13.1) .001*
Number of occlusal units 3.8 (5.4) 2.4 (4.1) 2.3 (3.9) 3.8 (5.1) .26
Maximum mouth opening (mm) 53.7 (7.5) 52.9 (11.8) 46.6 (11.4) 56.0 (9.8) .000**
Maximum bite force (Newton) 446 (384) 224 (233) 257 (330) 377 (344) .006*
Mixing ability index 18.5 (3.7) 24.1 (5.9) 23.4 (5.0) 21.0 (4.6) .000**
Abbreviations: D, dentate; ED, edentulous; FD, full denture; FDI, full denture on implants; NA, not applicable; TFM, tongue/floor of mouth.
a Chi-square test.
b Analysis of variance
*P < .01.; **P < .001.
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dental status, pT-classification, treatment, reconstruction, and
age (Table 1).
The mixed-model analysis showed that age, sex, smoking
and alcohol usage, pT classification, treatment modality, pres-
ence of an obturator prosthesis, and the type of reconstruction
did not significantly contribute to the MAI; therefore, these
factors were removed from the model. The assessment
moment, dental status, number of OU, and MMO did signifi-
cantly affect MAI. The location of the tumor and the MBF
also contributed significantly to the MAI, but the relative
effects differed at every assessment moment.
The following formula for the estimated MAI shows the
significant variables and their coefficients that were retained
in the model:
EstimatedMAI¼ 23:9þ t0ð2:05þ0:77Max
þ0:35Mandþ0TFMþ – 0:005MBFÞ
þ t1ð4:220:13Max1:40Mandþ0TFM
0:003MBFÞþ t2ð1:86þ3:28Max
þ1:38Mandþ0TFM0:001MBFÞ
þ t3ð2:62þ2:41Maxþ0:84Mand
þ0TFM0:002MBFÞþ t5ð−1:19Max
0:37Mand þ0TFM0:005MBFÞ
þ4:18EDþ0:22FD0:43FD
þ0:04FD&Dþ0:17FDI&D
1:91FDI&FDIþ0D0:04MMO
0:26OU
ð1Þ
Factors with a coefficient above 0 will increase the MAI
and thus reflect a worse masticatory performance. The
contribution of a single coefficient can only be interpreted
when all other variables remain stable. Figure 2 shows the
relative impact of all significant variables and can be inter-
preted as a visual presentation of the formula.
All assessment moments except t5 (t0, t1, t2, and t3)
increased the MAI (thus worse masticatory performance),
with the assessment moment immediately after surgery (t1)
having the highest coefficient. A dental status better than
edentulous, a higher number of OU, and an increased MMO
lowered the MAI (thus improve masticatory performance).
An edentulous state without a prosthesis increased the MAI
than all other dental states. A higher MBF lowered the MAI;
however, its impact was greatest before treatment and 5 years
after treatment. The influence of the tumor location differed
between the assessment stages; The TFM location was used
as reference category and equaled zero at every assessment
moment. At the baseline, 6 months, and 1 year after treat-
ment, maxillary and mandibular tumor location increased the
MAI, thus the TFM location performs better at those
moments. However, mandibulary tumor location and maxil-
lary tumor location lowered the MAI at the assessments
immediately after treatment and after 5 years.
The mean MAI before treatment was significantly lower
(thus better masticatory performance) in healthy controls
(x=18.5  3.7) than in all location groups (maxilla
x=24.1  5.9, mandible x=23.4  5.0, both P = .000, and
TFM x=21.0  4.6, P = .04). The general course of the
mean MAI scores for all primary tumor locations is an initial
deterioration after treatment, followed by a recovery over the
5 years after treatment. The recovery was mainly achieved
between 1 and 5 years after treatment (Figure 3). No recov-
ery plateau phase was observed for any of the groups.
FIGURE 2 Visual presentation of the significant variables and their coefficients of the estimated mixing ability index (MAI) formula. Variables without an
interaction with time are presented left of the y-axis. Impact on the intercept (MAI = 23.9) is shown. The variables without interaction with the assessment
moment are shown separately. The continuous variables (MMO, OU, MBF) are presented as the impact for the mean values of those variables. The mean
number of occlusal units was 2.9 and the mean MMO was 52 mm. Mean MBF differs per assessment moment and is 326 N before intervention, 145 N
directly after intervention, 193 N at 6 months, 194 N at 1 year, and 283 N at 5 years. Factors with positive outcomes increase the mixing ability outcome,
reflecting a deterioration of masticatory performance; for convenience, the y-axis has been inverted. *Reference category in mixed model, equals 0. D,
Dentate; ED, edentulous; FD, full denture; FDI, full denture on implants; max: maxilla; Mand, mandible; MBF, maximum bite force; MAI, mixing ability
index; MMO, maximum mouth opening; OU, occlusal units; TFM, tongue and floor of the mouth
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Five years after treatment, the mean MAI of patients who
had a maxillary primary tumor (MAI 19.3  1.1) was not sig-
nificantly different from those who had a tumor in the mandi-
ble (MAI 20.2  0.9, P = .46) or TFM (MAI 20.6  0.9,
P = .25). At 5 years after treatment, patients who had a man-
dibulary tumor or TFM tumor had worse MAI scores than the
healthy controls (P = .01 and P = .001, respectively); how-
ever, patients who had a maxillary tumor showed no signifi-
cant difference compared with the healthy controls at the end
of the 5-year follow-up period (P = .27; Figure 3).
Although pT-classification was not a significant factor
according to our mixed-model analysis, subjects who sur-
vived for 5 years after the treatment more often had lower
pT-classification outcomes (1 and 2) at the baseline than
those who died during the follow-up period (chi-squared
test: P = .04). The proportion of patients who died before
the end of the assessment period was not significantly differ-
ent between the patients with different tumor locations (chi-
squared test: P = .45).
4 | DISCUSSION
In this 5-year prospective study, factors with a significant
contribution to masticatory performance were identified for
patients who underwent a curative oncological intervention
because of an oral carcinoma. The relative impacts of these
factors on masticatory performance, assessed using the
MAT, were also quantified. Increased numbers of OU,
MBF, and MMO had a positive influence on masticatory
performance, whereas the absence of a functional prosthesis
in edentulous subjects had a negative impact.
The mean masticatory performance for patients with
TFM, mandible, and maxilla tumors was higher at 5 years
after treatment than it was before the treatment, which might
partially be explained by the fact that the tumor itself, espe-
cially in advanced stages, may cause pain and discomfort.
Also, between 1 and 5 years after treatment, rehabilitated
patients received their definitive prosthetics.25,26
4.1 | Comparison with existing literature
In contrast to the results of our 5-year prospective study,
2 previous cohort studies and 1 cross-sectional study
reported a lower masticatory performance compared with a
healthy control group, but study groups were small.11,15,27
In contrast to our longitudinal results, a negative effect
of age on masticatory performance in healthy subjects was
reported in 2 cross-sectional studies,28,29 but in another
cross-sectional study, no clear relationship was found
between these factors in healthy subjects.10
Using a comminution test in patients treated for all head
and neck cancer locations, a significant and clinically rele-
vant increase in bite force and objective masticatory perfor-
mance was demonstrated after definitive prosthodontic
rehabilitation.28 In the same study, the number of occluding
FIGURE 3 Estimates of mixing ability index (MAI) and SE rendered using a mixed-model analysis. The y-axis inverted for more values entered into the
model was that of the mean patient in the cohort, calculated using a least-squares method. The outcome presented is divided by the location of the primary
tumor over a 5-year follow up. Differences between groups are presented in the table under the figure. MAI ranges from 0 to 30, where 0 represents the best
and 30 the worst possible outcome; thus for convenience, the y-axis has been inverted. *A significant difference (P < .05) between that and the next
assessment; † A significant difference (P < .05) between 2 groups at the same assessment time point, calculated using a restricted maximum likelihood
approach. Only the assessment at 5 years after treatment of the maxillary tumor group was not significantly different from the control group (P = .27). Max,
Maxilla; Mand, Mandible; TFM, Tongue/Floor of the Mouth
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pairs of (pre)molars were found to influence masticatory per-
formance. Bite force has been previously reported to account
for up to 60% of the variance in masticatory performance in
healthy subjects.30 Other objective data in patients with both
head and neck cancer and healthy subjects found beneficial
effects of adequate prosthetic rehabilitation.17,31,32 In a system-
atic review, the importance of rehabilitating dentition, includ-
ing the use of dental implants to support a fixed prosthesis,
add OU, or support a removable prosthesis, was confirmed.33
Studies on patient-reported masticatory ability, however, found
little11 to no effect31,34 of prosthodontic treatment.
Although trismus has previously been identified in a sys-
tematic review as a negative influencer of masticatory per-
formance in head and neck oncology, however, from which
severity of MMO-restriction this negative impact occurs is
unknown.35 In our model, each millimeter of mouth opening
provides a 0.04 improvement in the MAI, so a reduction of
MMO from 55 to 30 mm deteriorates the MAI by 1.0 points,
which is a clinically relevant impact independent of all other
factors. In another prospective study using a logistic regres-
sion analysis on the same patient population, plus 20 patients
with oropharyngeal tumors, the prognostic factors of trismus
development have been presented. Lower pretreatment
MMO, maxillary or mandibulary tumor location and (post-
operative) radiotherapy increased the risk of the develop-
ment of trismus.13
Other studies found a 1-year postoperative improvement
in objective masticatory efficacy, determined using ATP-
grains and the MAT, respectively, in patients with a TFM
tumor, when compared with preoperative values. This effect
might be due to the effect of primary tumor discomfort on
the masticatory performance.15,36
In a cross-sectional study, patients who underwent a
maxillectomy showed better masticatory performance after
full oral rehabilitation than those who had a mandibulect-
omy, but their chewing ability was still inferior to healthy
full-denture wearers. However, the treatment groups in this
study were small.16
4.2 | Clinical implications
Masticatory performance is an important factor in posttreat-
ment quality of life for patients treated for head and neck
cancer.37 In general, functional outcomes are not the sole
contributors to quality of life, but they form a significant part
of a patient's well-being and are therefore important issues to
address.4–6 This study showed a number of factors that
impact masticatory performance during the rehabilitation of
patients treated for oral malignancies. The clinical signifi-
cance of the formula can calculate the estimated masticatory
performance for any patient with oral cavity, although infor-
mation such as bite force is usually not readily available in
daily practice. The factors found to significantly affect mas-
ticatory performance such as OU count, prosthetic status,
bite force, and mouth opening are all factors that need to be
considered when constructing the initial treatment plan. Pri-
mary consideration of reconstructive and rehabilitative
options in a multidisciplinary setting might ensure adequate
management of these factors. This includes the consideration
of digital planning for reconstruction and primary implant
placement by the head and neck surgeon and prosthodontist.
Additionally, beneficial effects of orofacial physiotherapy
have been reported in orthognatic surgery,38 but have yet to
be proven in patients with head and neck cancer.35 Finally,
thoughtful consideration should be given in maintaining OU
when clearing the dentition of potential foci in osteoradione-
crosis prevention. However, the presence of natural teeth
after radiotherapy necessitates patients to commit to lifelong
meticulous oral hygiene and frequent self-application of
fluoride, either as neutral sodium fluoride or a 1% gel
applied at least every other day to prevent radiation caries.39
We found that the initial tumor location has an effect on
masticatory performance. This factor cannot be influenced
but can be addressed during the pretreatment counseling to
optimize a patient's expectations regarding masticatory
performance.
4.3 | Strengths and limitations
The strengths of this study are its long follow-up, prospec-
tive design, large study population (N = 123), meticulous
data generation through testing, and thorough statistical anal-
ysis. The latter provided us the opportunity to correct for
missing values (participants who dropped out or died) and
adjust for repeated measures and an unequal distribution of
baseline clinical characteristics between groups. In this
cohort study, no subgroup analyses were performed on other
possible influential factors, such as lingual nerve removal,
the extent of surgery, or the specific location of radiotherapy,
due to the small subgroup sample sizes.
The mean estimate of the MAI was higher for patients at
5 years after treatment than before treatment, regardless of
the location of the tumor. A possible explanation for this is
that the mixed-model outcome is based on the remaining par-
ticipants at every assessment moment, which in this case
could influence the outcome. In addition, those who survived
for 5 years after their treatment had smaller tumors, and thus
smaller resections, than patients who died or dropped out of
the study before the 5-year assessment. This could have influ-
enced the mean outcome of masticatory performance.
Unfortunately, the healthy controls were only assessed
once, so changes in their masticatory performance over the
course of the follow-up could not be compared to the treat-
ment groups.
4.4 | Future research
Future research should focus on possible further recovery, or
a secondary decline, of masticatory performance after the
5-year posttreatment period.
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Tongue function is of great importance in mastica-
tion40,41; however, until now the influence of disabled ton-
gue function on masticatory performance was unknown for
patients treated for oral cancer. The clinical effects of stan-
dardized posttreatment physical therapy protocols have yet
to be evaluated.
4.5 | Conclusion
Oral cancer and its treatment drastically affect masticatory
performance, but it recovers to pretreatment levels in
patients who survive for 5 years. Masticatory performance in
patients with oral cancer is positively affected by having full
dentures or better, a higher number of OU, increased MMO,
elevated MBF, and having a maxillary rather than mandibu-
lar or TFM tumor location.
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